2020-10-31
- Sun Pharma Announces 5-Year Sustained Efficacy and Safety Results for ILUMYA® (tildrakizumab-asmn) in Patients with Moderate-to-Severe Plaque Psoriasis
- Can Democrats flip Texas? Kamala Harris visits Lone Star state as early voting there smashes record
- Kessler Topaz Meltzer & Check, LLP: Securities Fraud Class Action Filed Against Raytheon Technologies Corporation f/k/a Raytheon Company – RTX, RTN
- Fact check: A birthday tweet from Hillary Clinton was edited to be about Amy Coney Barrett
- New Data Presented at the European Academy of Dermatology and Venereology (EADV) 29th Congress
